RN

Ruksheda Nazli Syeda

Active Director Designated Partner DIN 10235199
DIN 10235199 First appointment Jul 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ruksheda Nazli Syeda

Data last updated:

Ruksheda Nazli Syeda is a Designated Partner at Sars Functional And Gynaecological Education And Research Llp (since 2023). The company operates in Healthcare.

DIN 10235199
Primary Designation Designated Partner
Industry Healthcare
First Appointment 11 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Jul 20232023Active

Board colleagues of Ruksheda Nazli Syeda

Directorship timeline

Open interactive timeline →
Sars Functional And Gynaecological Education And Research Llp
Premium access

Shareholding and investment profile for Ruksheda Nazli Syeda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruksheda Nazli Syeda

Ruksheda Nazli Syeda currently holds 1 directorship: Sars Functional And Gynaecological Education And Research Llp (Designated Partner, since 11 Jul 2023).

Ruksheda Nazli Syeda was first appointed on 11 Jul 2023 as Designated Partner at Sars Functional And Gynaecological Education And Research Llp.

The current boards of Ruksheda Nazli Syeda's companies include Sejal Saroj Ajmera (Sars Functional And Gynaecological Education And Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available